Evidence for antibody as a protective correlate for COVID-19 vaccines
Top Cited Papers
Open Access
- 24 May 2021
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 39 (32), 4423-4428
- https://doi.org/10.1016/j.vaccine.2021.05.063
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
This publication has 14 references indexed in Scilit:
- The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike proteinVirology, 2021
- Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentThe Lancet, 2021
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersThe New England Journal of Medicine, 2021
- SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent IndividualsThe Journal of Immunology, 2021
- Correlates of protection against SARS-CoV-2 in rhesus macaquesNature, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine, 2020
- Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19Signal Transduction and Targeted Therapy, 2020
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- A Framework for Assessing Immunological Correlates of Protection in Vaccine TrialsThe Journal of Infectious Diseases, 2007
- Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodiesVaccine, 2007